Janice Yiu

Ms. Janice Yiu

UCL, London, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Maria Irene BelliniMaria Irene Bellini
Maria Irene Bellini
MNMikhail Nozdrin
Mikhail Nozdrin
JYJanice Yiu
Janice Yiu
Vassilios PapaloisVassilios Papalois
Vassilios Papalois
Introduction: To match the current organ demand with organ availability from the donor pool, there has been a shift towards acceptance of extended criteria donors (ECD), often associated with longer ischemic times. Novel dynamic preservation techniques as hypothermic or normothermic machine perfusion (MP) are increasingly adopted, particularly for organs from ECDs. In this study, we compared the viability and incidence of reperfusion injury in kidneys and livers preserved with MP versus Static Cold Storage (SCS). Methods: Systematic review and meta-analysis with a search performed between February and March 2019. MEDLINE, EMBASE and Transplant Library were searched via OvidSP. The Cochrane Library and The Cochrane Central Register of Controlled Trials (CENTRAL) were also searched. English language filter was applied. Results: the systematic search generated 10,585 studies, finally leading to a total of 30 papers for meta-analysis of kidneys and livers. Hypothermic MP (HMP) statistically significantly lowered the incidence of primary nonfunction (PMN, p = 0.003) and delayed graft function (DGF, p < 0.00001) in kidneys compared to SCS, but not its duration. No difference was also noted for serum creatinine or eGFR post-transplantation, but overall kidneys preserved with HMP had a significantly longer one-year graft survival (OR: 1.61 95% CI: 1.02 to 2.53, p = 0.04). Differently from kidneys where the graft survival was affected, there was no significant difference in primary non function (PNF) for livers stored using SCS for those preserved by HMP and NMP. Machine perfusion demonstrated superior outcomes in early allograft dysfunction and post transplantation AST levels compared to SCS, but however, only HMP was able to significantly decrease serum bilirubin and biliary stricture incidence compared to SCS. Conclusions: MP improves DGF and one-year graft survival in kidney transplantation; it appears to mitigate early allograft dysfunction in livers, but more studies are needed to prove its potential superiority in relation to PNF in livers.

9 September 2019 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Maria Irene BelliniMaria Irene Bellini
Maria Irene Bellini
JYJanice Yiu
Janice Yiu
MNMikhail Nozdrin
Mikhail Nozdrin
Vassilios PapaloisVassilios Papalois
Vassilios Papalois
The recent advances in machine perfusion (MP) technology involve settings ranging between hypothermic, subnormothermic, and normothermic temperatures. Tissue level adenosine triphosphate (ATP) is a long-established marker of viability and functionality and is universal for all organs. In the midst of a growing number of complex clinical parameters for the quality assessment of graft prior to transplantation, a revisit of ATP may shed light on the underlying reconditioning mechanisms of different perfusion temperatures in the form of restoration of metabolic and energy status. This article aims to review and critically analyse animal and preclinical human studies (discarded grafts) during MP of three abdominal organs (liver, kidney, and pancreas) in which ATP was a primary endpoint. A selective review of recent novel reconditioning approaches relevant to mitigation of graft ischaemia-reperfusion injury via MP and for different perfusion temperatures was also conducted. With a current reiterated interest for oxygenation during MP, a re-introduction of tissue ATP levels may be valuable for graft viability assessment prior to transplantation. Further studies may help delineate the benefits of selective perfusion temperatures on organs viability.

7 August 2024 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
JYJanice Yiu
Janice Yiu
RTRavali Tippireddy
Ravali Tippireddy
LBLukla Biasi
Lukla Biasi
SPSanjay Patel
Sanjay Patel
PSPrakash Saha
Prakash Saha
HZHany Zayed
Hany Zayed

1 December 2020 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
JYJanice Yiu
Janice Yiu
ATA. Tahim
A. Tahim

5 June 2026 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
JYJanice Yiu
Janice Yiu
MAMohamed A. Abdelhalim
Mohamed A. Abdelhalim
AGAurelien Gueroult
Aurelien Gueroult
IIImashi Iddawela
Imashi Iddawela
APAshish Patel
Ashish Patel
BMBijan Modarai
Bijan Modarai
To define contemporary medium (3 - 5 years) and long term (>5 years) survival and durability outcomes after elective fenestrated and branched endovascular aortic repair for complex abdominal and thoraco-abdominal aneurysms and to assess the certainty of the available evidence. MEDLINE, Embase, and the Cochrane Library were searched from January 2000 to February 2026, supplemented by citation screening. Published Kaplan-Meier time to event data were digitised and reconstructed into individual patient datasets. Pooled survival probabilities were generated using validated methods for meta-analytic methods for survival curves. Certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation framework, and risk of bias was assessed with ROBINS-1 (v2). The protocol was registered in the International Prospective Register of Systematic Reviews (CRD42024565664). Twenty four studies comprising 8 886 patients were included. Pooled overall survival was 91.3% (95% confidence interval [CI] 90.7 - 91.9) at 1 year, 73.0% (95% CI 71.9 - 74.0) at 3 years, and 55.4% (95% CI 53.9 - 56.8) at 5 years. Estimated median overall survival was 6.36 years. Based on studies that reported this, at 5 years, freedom from aneurysm related mortality was 96.4% (95% CI 95.3 - 97.2), and freedom from re-intervention was 66.5% (95% CI 64.6 - 68.2). Target vessel patency, based on two studies, was 94.8% (95% CI 93.3 - 96.0). Certainty of evidence was low for overall survival, freedom from aneurysm related mortality and re-intervention, and very low for target vessel patency. Elective fenestrated and branched endovascular aortic repair provides durable aneurysm exclusion with low aneurysm related mortality. However, survival beyond 5 years declines substantially. There is a need for more robust survival data and improved tools to support patient selection, shared decision making, and assessment of anticipated benefit when considering prophylactic complex endovascular repair.

1 October 2022 in European Heart Journal
Verified
Journal Article
Open access
PDF file
JRJ Rastogi
J Rastogi
JHJ Ho
J Ho
JLJ Lazari
J Lazari
PJP Jageer
P Jageer
SDS Davis
S Davis
JBJ Bray
J Bray
Patients with anorexia nervosa (AN) are at higher risk of sudden cardiac death. Although the underlying aetiology for this association remains unclear. It may be related to prolongation of the QT interval, which can degenerate into fatal ventricular arrhythmias. However, the presence of prolonged heart rate-corrected QT interval (QTc) in AN remains controversial, and two previous meta-analyses on AN and QTc showed contradictory findings [1,2]. In this systematic review and meta-analysis, we aimed to evaluate if AN was associated with changes in the QTc interval and dispersion. MEDLINE, EMBASE and COCHRANE databases were systematically searched from inception to January 2021. Random-effects meta-analysis and meta-regression were used. The inclusion criteria were (i) confirmed diagnosis of AN, (ii) measurement of QTc on electrocardiogram and (iii) peer-reviewed articles. The primary endpoint of the study was the duration of the QTc interval calculated using the Bazett (QTcB), Hodges (QTcH), Fridericia (QTcF) and Framingham (QTcFr) formulae. The secondary endpoints were QT dispersion (QTd) and QTc dispersion (QTcd). The 25 eligible studies included 5687 patients (1862 AN, 3825 control) (Figure 1: PRISMA diagram). The majority of patients were female (96.3%) with a mean age between 14.3 to 31.0 years and mean duration of disease ranging from 9.1 to 129.6 months. The mean BMI ranged from 13.7 to 18.5 kg/m2. Pooled analysis did not show significant prolongation between AN versus control in QTcB (mean difference (MD) MD 4.9ms, 95% CI −3.2, 13.1ms, p=0.23; I2=95%; n=24/25 studies; Figure 2A), QTcH (MD 1.3ms, 95% CI −8.5, 11.2ms, p=0.79; I2=71%; n=3/25 studies), and QTcF (MD 3.1ms, 95% CI −21.6, 27.7ms, p=0.81; I2=97%; n=3/25 studies). Only two studies reporting QTcFr showed a significant prolongation between AN and control (MD 15.9ms, 95% CI 0.0, 31.8ms, p=0.05, I2=65%; n=2/25 studies; Figure 2B). However, QTd and QTcd were significantly greater in AN than control (MD 21.3ms, 95% CI 10.4, 32.3ms, p=0.0001, I2=94%; Figure 2C and MD 16.9ms, 95% CI 4.5, 29.3ms, p=0.007 I2=93%; Figure 2D, respectively). To the best of our knowledge, this is the largest meta-analysis of QTc in AN and the first meta-analysis exploring the significance of QTd and QTcd in AN. AN was not found to be associated with prolongation of QTc calculated using the Bazett, Fridericia and Hodges formulae. However, an association of AN with prolonged QTc was observed in the studies using the Framingham formula. More pronounced dispersion (QTd and QTcd) was also observed in patients with AN. Type of funding sources: None. Figure 1 Figure 2